French Observatory of Rare Malignant Tumors of the Ovary

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

To take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ARCAGY/ GINECO GROUP

Criteria

Inclusion Criteria:

• age > 18 years old

• germinal or sexual cords ovary tumors histologically proven

• first line or relapse treatment

• written informed consent

Exclusion Criteria:

• mental ineptitude to understand and follow the study